Therefore, we developed a clinical expansion protocol of mesenchymal stem cells MSCs. VagiVital® is Peptonic's hormone-free self-care product for the treatment of symptoms associated with vaginal atrophy. Läs mer om hur vi hanterar personuppgifter och cookies. The Ad-MSCs exhibited a stable morphology, and they preserved their surface marker characteristics and differentiation potentials into bone and fat lineages. This is important because such cryopreservation allows Ad-MSCs to be held on the shelf until their planned use s. VagiVital® is a trademark of Peptonic Medical.
The information was submitted for publication, through the agency of the contact person set out above, at 9 July
You have sent too many requests causing Linguee to block your computer
Orion's adjusted net sales in amounted to EUR 1, million and the company had about 3, employees. The information was submitted for publication, through the agency of the contact person set out above, at 29 June The development of Vagitocin® is on hold pending additional data on i. Our vision is to offer safe and effective treatments for women suffering from vaginal atrophy during menopause and after. Some features of this site may not work without it. Oxytocin improves cytological and histological profiles of vaginal atrophy in postmenopausal women. Här loggar du in för obegränsad läsning av allt innehåll på di.